Mexico
· Delayed Price · Currency is MXN Moderna Statistics
Total Valuation
Moderna has a market cap or net worth of MXN 238.74 billion. The enterprise value is 59.42 billion.
| Market Cap | 238.74B |
| Enterprise Value | 59.42B |
Important Dates
The last earnings date was Thursday, February 27, 2025.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.52% |
| Shares Change (QoQ) | -3.51% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 348.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 1.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.80 |
| EV / Sales | 0.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.70 |
Financial Position
The company has a current ratio of 3.67, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.67 |
| Quick Ratio | 3.45 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.18 |
| Interest Coverage | -164.38 |
Financial Efficiency
Return on equity (ROE) is -28.77% and return on invested capital (ROIC) is -18.44%.
| Return on Equity (ROE) | -28.77% |
| Return on Assets (ROA) | -15.14% |
| Return on Invested Capital (ROIC) | -18.44% |
| Return on Capital Employed (ROCE) | -33.05% |
| Revenue Per Employee | 11.63M |
| Profits Per Employee | -12.79M |
| Employee Count | 5,800 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 37.66 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.31% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -62.31% |
| 50-Day Moving Average | 764.55 |
| 200-Day Moving Average | 1,420.30 |
| Relative Strength Index (RSI) | 38.07 |
| Average Volume (20 Days) | 3,144 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.83 |
Income Statement
In the last 12 months, Moderna had revenue of MXN 67.43 billion and -74.20 billion in losses. Loss per share was -193.37.
| Revenue | 67.43B |
| Gross Profit | -57.74B |
| Operating Income | -82.20B |
| Pretax Income | -75.16B |
| Net Income | -74.20B |
| EBITDA | -78.27B |
| EBIT | -82.20B |
| Loss Per Share | -193.37 |
Balance Sheet
The company has 146.38 billion in cash and 15.57 billion in debt, giving a net cash position of 182.79 billion.
| Cash & Cash Equivalents | 146.38B |
| Total Debt | 15.57B |
| Net Cash | 182.79B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 227.15B |
| Book Value Per Share | 588.47 |
| Working Capital | 122.79B |
Cash Flow
In the last 12 months, operating cash flow was -62.60 billion and capital expenditures -21.90 billion, giving a free cash flow of -84.50 billion.
| Operating Cash Flow | -62.60B |
| Capital Expenditures | -21.90B |
| Free Cash Flow | -84.50B |
| FCF Per Share | n/a |
Margins
Gross margin is -85.63%, with operating and profit margins of -121.91% and -110.04%.
| Gross Margin | -85.63% |
| Operating Margin | -121.91% |
| Pretax Margin | -111.46% |
| Profit Margin | -110.04% |
| EBITDA Margin | -116.07% |
| EBIT Margin | -121.91% |
| FCF Margin | n/a |
Dividends & Yields
Moderna does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.52% |
| Shareholder Yield | -0.52% |
| Earnings Yield | -31.08% |
| FCF Yield | -35.39% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Moderna has an Altman Z-Score of 7.29.
| Altman Z-Score | 7.29 |
| Piotroski F-Score | n/a |